Firm
Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Matthew Grady of Wolf Greenfield says AI presents an opportunity in patent practice for stronger collaboration between in-house and outside counsel
Discussion hosted by Bird & Bird partners also hears that UK courts’ desire to determine FRAND rates could see the jurisdiction penalised in a similar way to China
Sponsored
Sponsored
-
Sponsored by Anand and AnandPravin Anand and Ashutosh Upadhyaya of Anand and Anand examine whether taste can function as a trademark in India, with insights drawn from international practice and examples of graphical representations -
Sponsored by MaiwaldMarco Stief of Maiwald argues that the District Court of The Hague missed an opportunity to clarify the uncertainty surrounding the term ‘first authorisation’ in Article 3(d) of the SPC Regulation in a recent judgment
-
Sponsored by Gün and PartnersThe ruling addresses the impact of device mark differences, proof of use, and well-known status arguments, say Hande Hançar Koç, Havva Yıldız, and Zeynep Berfin Ekinci of Gün and Partners
-
Sponsored by InspicosJakob Pade Frederiksen of Inspicos highlights how a recent ruling relating to the applicable standard for inventive step assessment diverges from the EPO’s problem-solution approach
-
Sponsored by InventaSpain’s Donut case shows how widespread linguistic use does not necessarily erode trademark rights. Diogo Antunes of Inventa examines how Spanish and Portuguese practice address lexicalisation, reputation, and the boundary between descriptiveness and genericide
-
Sponsored by That.LegalGillian Tan of That.Legal explains Singapore’s approach to goodwill in passing off and what two recent cases mean for pre-launch market entry
